Stephens Inc. AR trimmed its stake in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 5.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,031 shares of the insurance provider’s stock after selling 822 shares during the period. Stephens Inc. AR’s holdings in Allstate were worth $2,825,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of ALL. Arlington Trust Co LLC lifted its position in shares of Allstate by 261.8% during the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 89 shares in the last quarter. Hughes Financial Services LLC acquired a new position in shares of Allstate during the first quarter worth approximately $28,000. Hilltop National Bank acquired a new position in Allstate in the second quarter valued at approximately $34,000. Meeder Asset Management Inc. lifted its holdings in Allstate by 113.8% in the first quarter. Meeder Asset Management Inc. now owns 186 shares of the insurance provider’s stock valued at $39,000 after buying an additional 99 shares during the period. Finally, McClarren Financial Advisors Inc. acquired a new position in Allstate in the first quarter valued at approximately $43,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Stock Performance
NYSE ALL opened at $194.63 on Thursday. The firm has a 50-day moving average of $204.82 and a 200-day moving average of $200.79. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43. The stock has a market cap of $51.29 billion, a PE ratio of 9.15, a P/E/G ratio of 0.70 and a beta of 0.38. The Allstate Corporation has a 52-week low of $176.00 and a 52-week high of $215.70.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of Allstate in a report on Wednesday, October 8th. BMO Capital Markets increased their target price on shares of Allstate from $230.00 to $235.00 and gave the stock an “outperform” rating in a report on Wednesday, August 20th. Citigroup upgraded shares of Allstate to a “hold” rating in a report on Wednesday, August 13th. JPMorgan Chase & Co. increased their target price on shares of Allstate from $235.00 to $254.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Finally, Jefferies Financial Group increased their target price on shares of Allstate from $254.00 to $255.00 and gave the stock a “buy” rating in a report on Monday, August 11th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $234.60.
Read Our Latest Stock Analysis on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- How to Choose Top Rated Stocks
- Archer’s Recent String of Victories Signals a New Phase of Growth
- Best Aerospace Stocks Investing
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- Do ETFs Pay Dividends? What You Need to Know
- The Best AI for Picking Stocks, Ranked by Performance
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.